Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ...

An octopus-shaped nanomachine hijacks tumor ATP leakage to power a self-amplifying cycle of membrane damage, drug delivery, and metabolic collapse in cancer cells.

NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for improving outcomes for cancer patients, today announced that two poster ...

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced expansion cohort data ...

Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs distant from the primary site and are often difficult to identify. A research ...

Telix Pharmaceuticals delivered strong Q1'26 results with $230M revenue and reaffirmed FY26 guidance of $950–$970M, above ...